Personal information

Spain

Activities

Works (18)

HSP-CAR30 WITH A HIGH PROPORTION OF LESS-DIFFERENTIATED T CELLS PROMOTES DURABLE RESPONSES IN REFRACTORY CD30+ LYMPHOMA

Blood Journal
2025-01-22 | Journal article
Contributors: Ana Carolina Caballero Gonzalez; Cristina Ujaldón-Miró; Paula Pujol-Fernández; Rosanna Montserrat-Torres; Maria Guardiola-Perello; Eva Escudero-López; Irene Garcia-Cadenas; Albert Esquirol; Rodrigo Martino; Paola Jara-Bustamante et al.
Source: check_circle
Crossref

Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation

European Journal of Haematology
2024-12 | Journal article
Contributors: Sara Redondo; Irene García‐Cadenas; Albert Esquirol; J. M. Portos; Eva Iranzo; Miguel Arguello‐Tomas; Silvana Saavedra; Guadalupe Oñate; Ana‐Carolina Caballero; Ana Garrido et al.
Source: check_circle
Crossref

Cytomegalovirus DNA doubling time for early identification of clinically significant infection episodes in allogeneic hematopoietic stem cell transplant recipients undergoing primary Letermovir prophylaxis: A multicenter study

2024-12-16 | Preprint
Contributors: David Navarro; Estela Giménez; Irene García-Cadenas; Jose Luis Piñana; Eliseo Albert; Lourdes Vázquez; Alejandro Avendaño; Mónica Cabrero; Albert Esqu; Rodrigo Martino et al.
Source: check_circle
Crossref

Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies

Bone Marrow Transplantation
2024-10 | Journal article
Contributors: Maria Laura Fox; Irene García-Cadenas; Victor Navarro; Ariadna Pérez Martínez; Meriem Kara; Irene Sánchez Bazán; Christelle Ferra Coll; Rebeca Bailén; Leyre Bento; Rocío Parody et al.
Source: check_circle
Crossref

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

Bone Marrow Transplantation
2024-01 | Journal article
Contributors: Gérard Socié; Pere Barba; Arie Barlev; Jaime Sanz; Irene García-Cadenas; Patrice Chevallier; Franca Fagioli; Norma Guzman-Becerra; Deepali Kumar; Per Ljungman et al.
Source: check_circle
Crossref

Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation

Vox Sanguinis
2023-08 | Journal article
Contributors: Isabel Regalado‐Artamendi; Marta García‐Fasanella; Laura Medina; Jesus Fernandez‐Sojo; Albert Esquirol; Irene García‐Cadenas; Rodrigo Martino; Javier Briones; Jorge Sierra; Silvana Novelli
Source: check_circle
Crossref

Sequence matters: Total body irradiation (TBI)‐based myeloablative conditioning with post‐transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI

European Journal of Haematology
2023-07 | Journal article
Contributors: Sara Redondo; Irene García‐Cadenas; Antonio Vila; Albert Esquirol; J. M. Portos; Silvana Novelli; Silvana Saavedra; Carol Moreno; Ana Garrido; Miguel Arguello‐Tomas et al.
Source: check_circle
Crossref

Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation

European Journal of Haematology
2023-06 | Journal article
Contributors: Christelle Ferra Coll; Mireia Morgades de la Fe; Laura Prieto García; Carlos Pinho Vaz; María Inmaculada Heras Fernando; Rebeca Bailen Almorox; Irene Garcia‐Cadenas; Marisa Calabuig Muñoz; Teresa Zudaire Ripa; Joud Zanabili Al‐Sibai et al.
Source: check_circle
Crossref

Outcome Improvement Over Time in Reduced Intensity Conditioning Hematopoietic Transplantation: A 20 Years Experience

2023-02-17 | Preprint
Contributors: Albert Esqu; Irene García-Cadenas; Silvana Novelli; Ana Garrido; Ana Carolina Caballero; Guadalupe Oñate; Jordi López-Pardo; Sara Redondo; Miguel Arquello-Tomas; Silvanna Saavedra Gerosa et al.
Source: check_circle
Crossref

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation

Bone Marrow Transplantation
2022-02 | Journal article
Contributors: Rodrigo Martino; Irene García-Cadenas; Albert Esquirol
Source: check_circle
Crossref

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Bone Marrow Transplantation
2021-10 | Journal article
Contributors: Albert Esquirol; Maria Jesús Pascual; Mi kwon; Ariadna Pérez; Rocio Parody; Christelle Ferra; Irene Garcia Cadenas; Beatriz Herruzo; Nieves Dorado; Rafael Hernani et al.
Source: check_circle
Crossref

Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching

Bone Marrow Transplantation
2021-04 | Journal article
Contributors: García-Cadenas Irene; Esquirol Albert; Bosch-Vilaseca Anna; Awol Rahinatu; Novelli Silvana; Saavedra Silvana; Garrido Ana; López Jordi; Caballero Ana Carolina; Granell Miquel et al.
Source: check_circle
Crossref

Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors

Bone Marrow Transplantation
2021-04 | Journal article
Contributors: Juan Montoro; Pedro Chorão; Leyre Bento; Mónica Cabrero; Carmen Martín; Silvana Novelli; Irene García Cadenas; Gonzalo Gutiérrez; Oriana López-Godino; Christelle Ferrá et al.
Source: check_circle
Crossref

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

Leukemia & Lymphoma
2020-07-02 | Journal article
Contributors: María Laura Fox; Irene García-Cadenas; Ariadna Martínez Pérez; Guillermo Villacampa; José Luis Piñana; Guillermo Ortí; Juan Montoro; Elisa Roldán; Anna Bosch Vilaseca; Rodrigo Martino et al.
Source: check_circle
Crossref

Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature

Bone Marrow Transplantation
2020-06 | Journal article
Contributors: I. García-Cadenas; R. Awol; A. Esquirol; S. Saavedra; A. Bosch-Vilaseca; S. Novelli; A. Garrido; J. López; M. Granell; C. Moreno et al.
Source: check_circle
Crossref

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

Bone Marrow Transplantation
2020-03 | Journal article
Contributors: Virginia Escamilla Gómez; Valentín García-Gutiérrez; Lucía López Corral; Irene García Cadenas; Ariadna Pérez Martínez; Francisco J. Márquez Malaver; Teresa Caballero-Velázquez; Pedro A. González Sierra; María C. Viguria Alegría; Ingrid M. Parra Salinas et al.
Source: check_circle
Crossref

Frequency, characteristics, and outcome of PTLD after allo‐SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

European Journal of Haematology
2019-06 | Journal article
Contributors: Irene García‐Cadenas; Lucrecia Yáñez; Isidro Jarque; Rodrigo Martino; Jose Antonio Pérez‐Simón; David Valcárcel; Jaime Sanz; Arantxa Bermúdez; Cristina Muñoz; Cristina Calderón‐Cabrera et al.
Source: check_circle
Crossref

Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.

Source: Self-asserted source
Irene Garcia Cadenas

Peer review (5 reviews for 3 publications/grants)

Review activity for Advances in therapy. (1)
Review activity for Bone marrow transplantation (2)
Review activity for Journal for immunotherapy of cancer. (2)